Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Consultant [Member]
Common Stock [Member]
Consultant [Member]
Additional Paid-in Capital [Member]
Consultant [Member]
Board of Directors [Member]
Common Stock [Member]
Board of Directors [Member]
Additional Paid-in Capital [Member]
Board of Directors [Member]
June 30, 2020 Public Offering [Member]
Common Stock [Member]
June 30, 2020 Public Offering [Member]
Additional Paid-in Capital [Member]
June 30, 2020 Public Offering [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Treasury Stock [Member]
Total
Balance (in shares) at Dec. 31, 2019                   49,410,176          
Balance at Dec. 31, 2019                   $ 49,410 $ 96,082,324 $ (93,524,297) $ (67,274) $ (911,516) $ 1,628,647
Stock based compensation                     30,715       30,715
Common stock issued to employee for compensation expensed in prior periods (in shares)                   22,633          
Common stock issued to employee for compensation expensed in prior periods                   $ 23 14,989       15,012
Common stock to issued for services   $ 25,000 $ 25,000                        
Common stock to be issued to employees for bonuses                     171,046       171,046
Common stock issued for warrants exercised (in shares)                   460,725          
Common stock issued for warrants exercised                   $ 460 229,902       230,362
Net loss                       (1,600,215) (12,738)   (1,612,953)
Common stock issued for warrants exercised                   $ 460 229,902       230,362
Balance (in shares) at Mar. 31, 2020                   49,893,534          
Balance at Mar. 31, 2020                   $ 49,893 96,553,976 (95,124,512) (80,012) (911,516) 487,829
Balance (in shares) at Dec. 31, 2019                   49,410,176          
Balance at Dec. 31, 2019                   $ 49,410 96,082,324 (93,524,297) (67,274) (911,516) 1,628,647
Net loss                             (4,791,155)
Balance (in shares) at Jun. 30, 2020                   63,236,165          
Balance at Jun. 30, 2020                   $ 63,236 116,199,595 (95,148,899) (55,625) (911,516) 16,968,589
Balance (in shares) at Mar. 31, 2020                   49,893,534          
Balance at Mar. 31, 2020                   $ 49,893 96,553,976 (95,124,512) (80,012) (911,516) 487,829
Stock based compensation                     23,946       23,946
Common stock issued to employee for compensation expensed in prior periods (in shares)                   11,450          
Common stock issued to employee for compensation expensed in prior periods                   $ 11 14,989       15,000
Common stock to issued for services (in shares) 278,581     39,233                      
Common stock to issued for services $ 279 $ 381,520 381,799 $ 39 $ 53,967 $ 54,006                  
Common stock to be issued to employees for bonuses                     462,504       462,504
Common stock issued for warrants exercised (in shares)                   620,750          
Common stock issued for warrants exercised                   $ 621 718,029       718,650
Net loss                       (3,166,464) (11,738)   (3,178,202)
Common stock issued for warrants exercised                   $ 621 718,029       718,650
Common stock issued to employees for bonuses (in shares)                   202,617          
Common stock issued to employees for bonuses                   $ 203 (203)       0
Common stock issued in public offering (in shares)             6,770,000     5,420,000          
Common stock issued in public offering             $ 6,770 $ 13,369,845 $ 13,376,615 $ 5,420 4,621,022       4,626,442
Acquired controlling interest in Milestone Advanced Cosmetic Systems                       (24,387) 24,387    
Balance (in shares) at Jun. 30, 2020                   63,236,165          
Balance at Jun. 30, 2020                   $ 63,236 116,199,595 (95,148,899) (55,625) (911,516) 16,968,589
Balance (in shares) at Dec. 31, 2020                   64,171,435          
Balance at Dec. 31, 2020                   $ 64,171 117,934,696 (100,885,957) (94,426) (911,516) 16,106,968
Stock based compensation                     113,507       113,507
Common stock issued to employee for compensation expensed in prior periods (in shares)                   7,075          
Common stock issued to employee for compensation expensed in prior periods                   $ 7         7
Common stock to be issued for payment of consulting services expensed in prior periods (in shares) 40,010                            
Common stock to be issued for payment of consulting services expensed in prior periods $ 40   $ 40                        
Common stock to issued for services (in shares)       18,879                      
Common stock to issued for services       $ 18   18                  
Common stock issued to employee for stock options exercised (in shares)                   435,558          
Common stock issued to employee for stock options exercised                   $ 436 689,754       690,190
Common stock to be issued to employees for bonuses                     100,000       100,000
Common stock issued for warrants exercised (in shares)                   1,918,925          
Common stock issued for warrants exercised                   $ 1,919 3,010,297       3,012,216
Net loss                       (972,869) (12,988)   (985,857)
Common stock issued for warrants exercised                   $ 1,919 3,010,297       3,012,216
Balance (in shares) at Mar. 31, 2021                   66,591,882          
Balance at Mar. 31, 2021                   $ 66,591 121,848,254 (101,858,826) (107,414) (911,516) 19,037,089
Balance (in shares) at Dec. 31, 2020                   64,171,435          
Balance at Dec. 31, 2020                   $ 64,171 117,934,696 (100,885,957) (94,426) (911,516) 16,106,968
Net loss                             (3,682,650)
Balance (in shares) at Jun. 30, 2021                   67,055,869          
Balance at Jun. 30, 2021                   $ 67,055 123,075,664 (104,539,294) (123,739) (911,516) 17,568,170
Balance (in shares) at Mar. 31, 2021                   66,591,882          
Balance at Mar. 31, 2021                   $ 66,591 121,848,254 (101,858,826) (107,414) (911,516) 19,037,089
Stock based compensation                     193,824       193,824
Common stock issued to employee for compensation expensed in prior periods (in shares)                   4,202          
Common stock issued to employee for compensation expensed in prior periods                   $ 4 14,996       15,000
Common stock to be issued for payment of consulting services expensed in prior periods (in shares)                   96,018          
Common stock to be issued for payment of consulting services expensed in prior periods                   $ 94 262,589       262,683
Common stock to issued for services (in shares)       277,767                      
Common stock to issued for services       $ 280 $ 617,887 $ 618,167                  
Common stock issued for warrants exercised (in shares)                   86,000          
Common stock issued for warrants exercised                   $ 86 138,114       138,200
Net loss                       (2,680,468) (16,325)   (2,696,793)
Common stock issued for warrants exercised                   $ 86 138,114       138,200
Balance (in shares) at Jun. 30, 2021                   67,055,869          
Balance at Jun. 30, 2021                   $ 67,055 $ 123,075,664 $ (104,539,294) $ (123,739) $ (911,516) $ 17,568,170